@TogetherTrial interim results are out.
Fluvoxamine is deemed a success, Ivermectin not.
10 days of treatment given to Fluvoxamine, but only 3 to Ivermectin: like fighting one hand tied behind your back given the expected mode of action.
https://rethinkingclinicaltrials.org/news/august-6-2021-early-treatment-of-covid-19-with-repurposed-therapies-the-together-adaptive-platform-trial-edward-mills-phd-frcp/ …pic.twitter.com/zqtkJNyOSD